Skip to main content

Advertisement

Log in

Characterization of Three Crystalline Forms (VIII, XI, and XII) and the Amorphous Form (V) of Delavirdine Mesylate Using 13C CP/MAS NMR

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The application of solid-state nuclear magnetic resonance (NMR) characterization of three crystalline forms (VIII, XI, XII) and the amorphous form V of delavirdine mesylate (DLV-M) is presented.

Methods. Conventional 13C CP (cross-polarization)/MAS (magic angle spinning) NMR and related spectral editing methods were employed. NMR relaxation times (T1pH, T1H, and T1C) were also measured.

Results. Distinctly different spectral features among the four solid forms were observed, indicating high sensitivity of 13C NMR to the variations in solid structure. Assessment based on NMR data suggests that both anhydrous forms VIII and XI may contain one molecule per asymmetric unit. DLV may adopt a similar molecular conformation in the two forms. In contrast, form XII is found to consist of two molecules per asymmetric unit. Molecule conformation of DLV in forms VIII, XI, and XII is altered from the dominant conformer in solution. The amorphous form V may contain DLV molecules of a variety of conformations. NMR relaxation times (TlpH, T1H, and T1C) provide valuable information about the motional characteristics in these solids. Values and the rank order of TlpH, T1H, and T1C also reveal significant differences in local environments and the short range order among the four forms.

Conclusions. Four solid forms of DLV-M (V, VIII, XI. and XII) can be distinctly differentiated by 13C CP/MAS NMR spectroscopy and their structural difference can be partially revealed without obtaining single crystal data. NMR relaxation times reveal motion dynamics and aid structural elucidation for these forms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. I. W. Althaus, J. J. Chou, A. J. Gonzales, M. R. Deibel, K-C. Chou, F. J. Kezdy, D. L. Romero, R. C. Thomas, P. A. Aristoff, W. G. Tarpley, and F. Reusser. Kinetic studies with the nonnucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152E. Biochemical Pharmacology 47:2017–2028 (1994).

    PubMed  Google Scholar 

  2. M. S. Bergren, R. S. Chao, P. A. Meulman, R. W. Sarver, M. A. Lyster, J. L. Havens, and M. Hawley. Solid phase diversity of delavirdine mesylate. J. Pharm. Sci. 85:830–837 (1996).

    Google Scholar 

  3. H. Martinez, S. R. Byrn, and R. R. Pfeiffer. Solid state chemistry and crystal structure of cefactlor dihydrate. Pharm. Res. 7:147–153 (1990).

    PubMed  Google Scholar 

  4. S. R. Byrn, P. A. Sutton, B. Tobias, J. Frye, and P. Main. The crystal structure, solid-state NMR spectra and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate. J.A.C.S. 110:1609–1614 (1988).

    Google Scholar 

  5. G. A. Jeffrey, R. A. Wood, P. E. Pfeffer, and K. B. Hicks. Crystal structure and solid-state NMR analysis of lactulose. J.A.C.S. 105:2128–2133 (1983).

    Google Scholar 

  6. R. K. Harris, A. M. Kenwright, B. J. Say, and R. R. Yeung. Cross-polarization/magic angle spinning NMR studies of polymorphism: cortisone acetate. Spectrochim. Acta. 46A:927–935 (1990).

    Google Scholar 

  7. R. A. Fletton, R. W. Lancaster, R. K. Harris, K. J. Packer, D. N. Waters, and A. Yeadon. A comparative spectroscopic investigation of two polymorphs of 4′-methyl-2′-nitroacetanilide using solid-state infrared and high resolution solid-state nuclear magnetic resonance spectroscopy. J. Chem. Soc. Perkin. Trans. II 1705–1709 (1986).

    Google Scholar 

  8. N. J. Clayden, C. M. Dobson, L. Y. Lian, and J. M. Twyman. A solid-state 13C nuclear magnetic resonance study of the conformational states of penicillins. J. Chem. Soc. Perkin. Trans. II 1933–1940 (1986).

    Google Scholar 

  9. D. L. VanderHart. Influence of molecular packing on solid-state 13C chemical shifts. The n-alkanes. J. Mag. Res. 44:117–125 (1981).

    Google Scholar 

  10. L. E. Diaz, F. Morin, C. L. Mayne, D. M. Grant, and C. Chang. Conformational analysis of DL-, L-, and D-methionine by solid-state 13C NMR spectroscopy. Mag. Res. Chem. 24:167–170 (1986).

    Google Scholar 

  11. F. G. Morin, W. J. Horton, D. M. Grant, D. K. Dalling, and R. J. Pugmire. Carbon-13 magnetic resonance of hydroaromatics. 2. Conformation of tetralin and tetrahydroanthracene and their methyl derivations. J.A.C.S. 105:3992–3998 (1983).

    Google Scholar 

  12. D. K. Dalling, K. W. Zilm, D. M. Grant, W. A. Heeschan, W. J. Horton, and R. J. Pugmire. A solution and solid carbon-13 magnetic resonance study of the conformation of 9,10-dihydronthracene and methylated derivatives. J.A.C.S. 103:4817–4824 (1981).

    Google Scholar 

  13. C. E. Brown, S. C. Roerig, V. T. Burger, R. B. Cody, Jr., and J. M. Fujimoto. Analgesic potencies of morphine 3-and 6-sulfates after intracerebroventricular administration in mice: Relationship to structural characterization defined by mass spectrometry and nuclear magnetic resonance. J. Pharm. Sci. 74:821–824 (1985).

    PubMed  Google Scholar 

  14. M. Bardet, A. Rousseau, and M. Vincedon. High resolution solid-state 13C CP/MAS NMR study of scleroglucan hydration. Mag. Res. Chem. 5:886–892 (1993).

    Google Scholar 

  15. M. H. Frey and S. J. Opella. Observation of conformationally distinct proline residues in two cyclic peptides by solid-state nuclear magnetic resonance. J.A.C.S. 103:467–468 (1981).

    Google Scholar 

  16. P. Gao. Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP/MAS NMR. Pharm. Res. 13:1095–1104 (1996).

    PubMed  Google Scholar 

  17. C. A. Fyfe. Solid State NMR for Chemists. CFC Press, Guelph, Canada, 1983. Chapter 8.

    Google Scholar 

  18. X. Wu and K. W. Zilm. Complete spectral editing CPMAS NMR. J. Mag. Res. A. 102:205–213 (1993).

    Google Scholar 

  19. J. S. Fyre and G. E. Maciel. Setting the magic angle using a quadrupolar nuclide. J. Mag. Res. 48:125–131 (1982).

    Google Scholar 

  20. L. W. Jelinski and M. T. Melchior. High-resolution NMR of solids. in C. Dybowski and R. L. Lichter (eds.), NMR Spectroscopy Techniques. Marcel Dekker, Inc., New York, 1985.

    Google Scholar 

  21. K. A. Farley, G. S. Walker, R. H. Robins, J. E. Kupstas-Guido, W. K. Dulholke, D. L. Romero, R. A. Morge, P. A. Meulman, R. S. Chao, J. L. Havens, J. R. Gage, M. A. Lyster, P. E. Fagerness, and G. E. Martin. Spectroscopic studies of delavirdine mesylate (U-90152T) a bis(heteroary)piperazine (BHAP) HIV reverse transcriptase inhibitor. J. Heterocyclic. Chem. 33:493–497 (1996).

    Google Scholar 

  22. J. L. Koenig. Spectroscopy of Polymers. ACS, Washington D.C., 1992, pg 267–277.

    Google Scholar 

  23. A. Naito, S. Ganapathy, K. Akasaka, and C. A. McDowell. Spinlattice relaxation of 13C in solid aminoacids using the CP/MAS technique. J. Mag. Res. 54:226–235–5856 (1983).

    Google Scholar 

  24. R. K. Harris. Nuclear Magnetic Resonance Spectroscopy. Pitman Publishing, Inc., Marshfield, MA, 1983. Chapter 6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaou, P. Characterization of Three Crystalline Forms (VIII, XI, and XII) and the Amorphous Form (V) of Delavirdine Mesylate Using 13C CP/MAS NMR. Pharm Res 15, 1425–1433 (1998). https://doi.org/10.1023/A:1011909907031

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011909907031

Navigation